Advertisement

Topics

Janssen's prostate cancer drug approved by FDA

04:56 EST 15 Feb 2018 | SmartBrief

Johnson & Johnson unit Janssen Pharmaceuticals' Erleada, or apalutamide, was approved by the FDA under a priority review stat -More

Original Article: Janssen's prostate cancer drug approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Janssen's prostate cancer drug approved by FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...